Open AccessIdentification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials
Author(s) -
JianGuo Zhou,
Yu Zeng,
Haitao Wang,
Sanli Jin,
Yunjia Wang,
Sisi He,
Benjamin Frey,
Rainer Fietkau,
Markus Hecht,
Hu Ma,
Wenchuan Zhang,
Udo S. Gaipl
Publication year - 2022
Publication title -
therapeutic advances in medical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 49
eISSN - 1758-8359
pISSN - 1758-8340
DOI - 10.1177/17588359221126154
Subject(s) - medicine , oncology , clear cell renal cell carcinoma , hazard ratio , cohort , proportional hazards model , renal cell carcinoma , nivolumab , cancer research , immunotherapy , confidence interval , cancer